Glenn Markov, Rejuvenation Technologies co-founder & COO (L) and John Ramunas, co-founder & CEO (Photographer: Erin Beach)
Exclusive: Khosla Ventures leads seed round in mRNA biotech looking to reverse aging by lengthening telomeres
A tiny biotech startup called Rejuvenation Technologies is the latest to chase a massive ambition in reversing aging, a buzzy and often controversial research area …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.